Printer Friendly

MEDISYS ANNOUNCES ANOTHER RECORD QUARTER

 MEDISYS ANNOUNCES ANOTHER RECORD QUARTER
 MINNEAPOLIS, July 27 /PRNewswire/ -- Medisys, Inc. (NASDAQ: MEDS),


announced today that its net revenues increased 88 percent to $4.1 million and its net income increased 215 percent to $357,511 for its second quarter ended June 30, 1992, as compared to the same quarter in the prior year. Year-to-date net revenues increased 76 percent to $7.0 million and its net income increased 206 percent to $632,298.
 Net revenues from existing locations increased approximately 55 percent for the second quarter and year-to-date as compared to the same periods in the prior year. Operations in Arizona are included since May 1992. The increase in net income was primarily due to the increase in net revenues and additionally due to interest income on investment of proceeds from the company's public stock offering completed in January 1992.
 "Our continued record of substantial earnings increases, in combination with the addition of another successful acquisition, underscore our ability to achieve profitable growth in the home infusion therapy industry," said William J. Brummond, Medisys' chief executive officer.
 During the quarter Medisys completed the acquisition of Phoenix- based Pharmacy Consultants of Arizona. Pharmacy Consultants is a provider of comprehensive pharmacy services to long-term care and retirement communities. Such services include prescription dispensing, pharmaceutical consulting, IV therapy, enteral therapy and medical supplies. Its revenues for the 12-month period ended March 31, 1992, were approximately $3.7 million.
 "We feel this acquisition fits well with the objectives we have identified for our Long Term Care Program. It represents a continuation of the expansion strategy we outlined for 1992," said Brummond. "Pharmacy Consultants will serve as a base from which to grow our home IV therapy business in yet another market."
 Medisys, Inc. provides comprehensive home infusion therapy services and products through centers in Minnesota, Missouri, Wisconsin, Texas and Arizona, under the name "CareVan Medical Systems." Home infusion therapy involves the intravenous or other administration of physician- prescribed nutrients, antibiotics, chemotherapeutic agents and other medications to patients in their homes.
 MEDISYS FINANCIAL RESULTS
 STATEMENTS OF OPERATIONS
 Three Months Ended Percent
 6/30/92 6/30/91 Increase
 Net revenues $4,060,380 $2,160,670 87.9
 Income from operations 517,913 206,790 150.5
 Net income $357,511 $113,692 214.5
 Net income per common share $0.06 $0.03 100.0
 Weighted average common shares
 outstanding 6,022,000 3,737,000 61.1
 Six Months Ended Percent
 6/30/92 6/30/91 Increase
 Net revenues $6,969,139 $3,966,159 75.7
 Income from operations 882,231 413,503 113.4
 Net income $632,298 $206,380 206.4
 Net income per common share $0.11 $0.06 83.3
 Weighted average common shares
 outstanding 6,004,000 3,595,000 67.0
 BALANCE SHEETS
 6/30/92 12/31/91
 Assets
 Current assets:
 Cash and cash equivalents $8,850,781 $9,256,859
 Accounts receivable, net 6,698,876 4,806,909
 Other 973,274 497,151
 Total current assets 16,522,931 14,560,919
 Equipment and leaseholds, net 977,993 492,118
 Intangible assets, net 1,864,366 289,286
 Total assets $19,365,290 $15,342,323
 Liabilities and stockholders' equity
 Current liabilities $2,083,464 1,620,698
 Long-term liabilities 1,069,472 233,050
 Minority interest 337,440 285,394
 Total stockholders' equity 15,874,914 13,203,181
 Total liabilities and
 stockholders' equity $19,365,290 $15,342,?
 -0- 7/27/92
 /CONTACT: William Brummond or David Byrd, both of Medisys, 612-835-8300/
 (MEDS) CO: Medisys, Inc. ST: Minnesota IN: MTC SU: ERN


KH -- MN007 -- 3664 07/27/92 16:32 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 27, 1992
Words:612
Previous Article:ONCOR REPORTS RECORD NET PRODUCT SALES IN SECOND QUARTER ENDED JUNE 30, 1992
Next Article:UTILITY WORKERS LOCAL 223 PETITIONS MPSC TO INTERVENE AT DETROIT EDISON'S NEXT RATE CASE HEARING
Topics:


Related Articles
MEDISYS ANNOUNCES THIRD QUARTER RESULTS
MEDISYS ACQUIRES PHARMACY CONSULTANTS OF ARIZONA
MEDISYS TO ACQUIRE PHARMACY CONSULTANTS OF ARIZONA
MEDISYS REPORTS THIRD QUARTER EARNINGS PER SHARE
MEDISYS ANNOUNCES THIRD QUARTER/NINE MONTHS RESULTS
MEDISYS AGREES TO ACQUIRE PHARMACY VENTURES, INC.
MEDISYS ANNOUNCES YEAR END RESULTS
MEDISYS ANNOUNCES THIRD QUARTER RESULTS
MEDISYS ANNOUNCES YEAR END RESULTS
MEDISYS ANNOUNCES FIRST QUARTER RESULTS

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters